APA Citation

Gallant, J., Sheehan, J. H., Shaver, T. M., Bailey, M., Lipson, D., Chandramohan, R., . . . Lovly, C. M. (2015). EGFR kinase domain duplication (EGFR-KDD) is a novel oncogenic driver in lung cancer that is clinically responsive to afatinib. Cancer Discov.

Citação norma Chicago

Gallant, Jean-Nicolas, et al. "EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib." Cancer Discov 2015.

MLA Citation

Gallant, Jean-Nicolas, et al. "EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib." Cancer Discov 2015.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.